PFE weakness, ABT strength attributed to EULAR 2011 abstracts
The weakness in shares of Pfizer (PFE) and corresponding strength in shares of Abbott (ABT) is being attributed to abstracts from the EULAR 2011 conference in London, which starts May 28. EULAR is the European League Against Rheumatism.